Immunethep is a biotech startup company that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. We are working on preventing and treating infectious diseases to improve global health (SDG#3) for a safer tomorrow free of AntiMicrobial Resistance (AMR). We will accomplish our mission by developing anti-infective immunotherapies that potentiate a natural and strong immune response from the infected host, reducing the disease burden and mortality rates.
View Top Employees from IMMUNETHEPWebsite | http://www.immunethep.com |
Revenue | $6 million |
Employees | 19 (11 on RocketReach) |
Founded | 2014 |
Address | Biocant Parknucleo 04 Lote 3, Cantanhede, Coimbra 3060-197, PT |
Phone | +351 231 410 890 |
Technologies |
HTML,
reCAPTCHA,
Nginx
+4 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Drug Discovery, Anti-bacterial immunotherapies, Business Services, Biotechnology, Prevent infections from multi-resistant bacteria |
Web Rank | 13 Million |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular IMMUNETHEP employee's phone or email?
The IMMUNETHEP annual revenue was $6 million in 2024.
Pedro Castanheira is the Head of Protein Sciences of IMMUNETHEP.
11 people are employed at IMMUNETHEP.
IMMUNETHEP is based in Cantanhede, Coimbra.
The NAICS codes for IMMUNETHEP are [541713, 541, 54171, 54, 5417].
The SIC codes for IMMUNETHEP are [873, 87].